GOLDMAN SACHS GROUP INC - MARKER THERAPEUTICS INC ownership

MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 67 filers reported holding MARKER THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of MARKER THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$32,000
-56.8%
33,822
-23.2%
0.00%
Q3 2021$74,000
-80.5%
44,055
-67.7%
0.00%
Q2 2021$380,000
+578.6%
136,241
+442.8%
0.00%
Q1 2021$56,000
+40.0%
25,100
-9.0%
0.00%
Q4 2020$40,000
-37.5%
27,594
-35.8%
0.00%
Q3 2020$64,000
-45.8%
42,970
-24.6%
0.00%
Q2 2020$118,000
-4.8%
57,015
+31.8%
0.00%
Q4 2019$124,000
+67.6%
43,253
+197.8%
0.00%
Q3 2019$74,000
-84.4%
14,526
-79.8%
0.00%
Q1 2019$474,00071,7490.00%
Other shareholders
MARKER THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Aisling Capital Management LP 2,000,000$15,840,0006.76%
NEA Management Company, LLC 5,000,000$39,600,0002.77%
APIS CAPITAL ADVISORS, LLC 90,000$713,0001.07%
683 Capital Management, LLC 560,000$4,435,0000.40%
Perceptive Advisors 2,000,000$15,840,0000.36%
One68 Global Capital, LLC 30,000$238,0000.30%
CAXTON CORP 23,915$189,0000.22%
Riggs Asset Managment Co. Inc. 46,019$364,0000.20%
MYDA Advisors LLC 68,000$539,0000.18%
MYDA Advisors LLC 68,100$539,0000.18%
View complete list of MARKER THERAPEUTICS INC shareholders